| Product Code: ETC9625958 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Oncology NGS Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Oncology NGS Market - Industry Life Cycle |
3.4 Taiwan Oncology NGS Market - Porter's Five Forces |
3.5 Taiwan Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Taiwan Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Taiwan Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Taiwan Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Taiwan Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Taiwan Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Taiwan |
4.2.2 Technological advancements in Next-Generation Sequencing (NGS) for oncology |
4.2.3 Growing demand for personalized medicine in oncology |
4.3 Market Restraints |
4.3.1 High cost associated with NGS testing |
4.3.2 Limited reimbursement policies for NGS in oncology |
4.3.3 Lack of skilled professionals in interpreting NGS data accurately |
5 Taiwan Oncology NGS Market Trends |
6 Taiwan Oncology NGS Market, By Types |
6.1 Taiwan Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Taiwan Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Taiwan Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Taiwan Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Taiwan Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Taiwan Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Taiwan Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Taiwan Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Taiwan Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Taiwan Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Taiwan Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Taiwan Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Taiwan Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Taiwan Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Taiwan Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Taiwan Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Taiwan Oncology NGS Market Import-Export Trade Statistics |
7.1 Taiwan Oncology NGS Market Export to Major Countries |
7.2 Taiwan Oncology NGS Market Imports from Major Countries |
8 Taiwan Oncology NGS Market Key Performance Indicators |
8.1 Number of new oncology NGS tests performed annually in Taiwan |
8.2 Adoption rate of NGS technologies in oncology clinics |
8.3 Research and development investment in oncology NGS technologies |
8.4 Percentage of oncologists trained in NGS data interpretation |
8.5 Patient outcomes improvement rate due to personalized medicine based on NGS results |
9 Taiwan Oncology NGS Market - Opportunity Assessment |
9.1 Taiwan Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Taiwan Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Taiwan Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Taiwan Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Taiwan Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Taiwan Oncology NGS Market - Competitive Landscape |
10.1 Taiwan Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here